These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 10629552

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
    Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W.
    J Pathol; 1999 Mar; 187(4):396-402. PubMed ID: 10398097
    [Abstract] [Full Text] [Related]

  • 3. Patterns of chromosomal alterations in breast ductal carcinoma in situ.
    Hwang ES, DeVries S, Chew KL, Moore DH, Kerlikowske K, Thor A, Ljung BM, Waldman FM.
    Clin Cancer Res; 2004 Aug 01; 10(15):5160-7. PubMed ID: 15297420
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
    Mommers EC, Leonhart AM, Falix F, Michalides R, Meijer CJ, Baak JP, Diest PJ.
    J Pathol; 2001 Jul 01; 194(3):327-33. PubMed ID: 11439365
    [Abstract] [Full Text] [Related]

  • 8. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
    Wärnberg F, Nordgren H, Bergkvist L, Holmberg L.
    Br J Cancer; 2001 Sep 14; 85(6):869-74. PubMed ID: 11556839
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Sep 14; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 11. Molecular cytogenetics of primary breast cancer by CGH.
    Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP.
    Genes Chromosomes Cancer; 1998 Mar 14; 21(3):177-84. PubMed ID: 9523192
    [Abstract] [Full Text] [Related]

  • 12. Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes.
    Vanden Bempt I, Vanhentenrijk V, Drijkoningen M, De Wolf-Peeters C.
    J Pathol; 2006 Mar 14; 208(4):486-94. PubMed ID: 16402338
    [Abstract] [Full Text] [Related]

  • 13. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E.
    Cancer Res; 1996 Nov 15; 56(22):5260-5. PubMed ID: 8912866
    [Abstract] [Full Text] [Related]

  • 14. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
    Kuukasjärvi T, Karhu R, Tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J.
    Cancer Res; 1997 Apr 15; 57(8):1597-604. PubMed ID: 9108466
    [Abstract] [Full Text] [Related]

  • 15. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
    Stange DE, Radlwimmer B, Schubert F, Traub F, Pich A, Toedt G, Mendrzyk F, Lehmann U, Eils R, Kreipe H, Lichter P.
    Clin Cancer Res; 2006 Jan 15; 12(2):345-52. PubMed ID: 16428471
    [Abstract] [Full Text] [Related]

  • 16. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, Rosen PP.
    Am J Surg Pathol; 2009 Apr 15; 33(4):496-504. PubMed ID: 19047897
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
    Vos CB, Ter Haar NT, Peterse JL, Cornelisse CJ, van de Vijver MJ.
    J Pathol; 1999 Feb 15; 187(3):279-84. PubMed ID: 10398079
    [Abstract] [Full Text] [Related]

  • 20. Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma.
    Tawfik OW, Kimler BF, Davis M, Donahue JK, Persons DL, Fan F, Hagemeister S, Thomas P, Connor C, Jewell W, Fabian CJ.
    Histopathology; 2006 Feb 15; 48(3):258-67. PubMed ID: 16430472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.